Mark Moore, a Certified Registered Nurse Anesthetist (CRNA) and Founder/CEO of PrepTech, has been working in the medical industry for over 30 years. Moore has made it part of his life’s mission to develop innovative methods for improving the way he and fellow healthcare professionals can work smarter and safer in operating rooms.
To bring innovative medical devices to market, Moore formed a team of healthcare professionals including Co-founder/Medical Officer Erich Wolf, MD, PhD, Biomedical Engineer and Neurosurgeon. After securing several Utility Patents for ULTRAPREP™, Moore and Wolf expanded their team to include several medical advisors, physicians, manufacturers, legal consultants, and other business professionals.
ADVENT OF ISOCUBE™
Since the Taiwan-based plexiglass “aerosol box” impetus in March 2020, PrepTech has created a series of protective barrier devices, now patent-pending and being manufactured around the US.
In May 2020, the FDA released a “generic” Emergency Use Authorization (EUA) of “Protective Barrier Enclosures” designed with specific guidelines to protect healthcare workers. Trademarked as ISOCUBE™, PrepTech’s barriers conformed to the FDA’s EUA guidelines and we are now seeking our own EUA.
Two main ISOCUBE™ devices planned for commercialization by PrepTech, including a cleanable stainless-steel (SS) device with disposable bag/drapes and a fully disposable (single use) wire framed device with similar disposable bag/drape as the SS units. Single-use devices are perfect for healthcare facilities, medical transportation, industrial plants, and other facilities that do not wish to disinfect isolettes after each use.
ULTRAPREP™ CLINICAL TRIALS AND COVID-19
The company’s first device, ULTRAPREP™, is registered with the FDA as a Class 1 exempt medical device and are now available for purchase on this website and through select distributors.
In a 114-patient clinical trial on extremity surgeries, ULTRAPREP™ proved to save 6-9 minutes per surgery by shifting OR skin prep to outside the OR. For hospitals focused on better healthcare outcomes, this can mean more than a 20 to 30% increase in OR efficiency!
Prep Tech was beginning an additional clinical trial when the COVID-19 pandemic started. This time-and-motion trial delineating specific OR personnel time reallocation and hospital cost savings was abruptly postponed and the company shifted its resources to helping protect healthcare workers with isolettes.
Partnering with the Army
In April 2020, PrepTech was made aware that the U.S. Army was developing a Covid-19 Airway Management Isolation Chamber (CAMIC) similar in many ways to ISOCUBE™. After a series of collaborative discussions with the Army’s Tech Transfer office, PrepTech was granted a license agreement to produce a commercially available CAMIC device. The FDA granted a EUA specifically for the CAMIC.